Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


AI finds microbial signatures in tumours and blood across cancer types

Access options

Rent or buy this article

Prices vary by article type



Prices may be subject to local taxes which are calculated during checkout

Nature 579, 502-503 (2020)



  1. Helmink, B. A., Khan, M. A. W., Hermann, A., Gopalakrishnan, V. & Wargo, J. A. Nature Med. 25, 377–388 (2019).

    Article  PubMed  Google Scholar 

  2. Dejea, C. M. et al. Proc. Natl Acad. Sci. USA 111, 18321–18326 (2014).

    Article  PubMed  Google Scholar 

  3. Kostic, A. D. et al. Cell Host Microbe 14, 207–215 (2013).

    Article  PubMed  Google Scholar 

  4. Marshall, B. J. & Warren, J. R. Lancet 323, 1311–1315 (1984).

    Article  Google Scholar 

  5. Bullman, S. et al. Science 358, 1443–1448 (2017).

    Article  PubMed  Google Scholar 

  6. Robinson, K. M., Crabtree, J., Mattick, J. S. A., Anderson, K. E. & Dunning Hotopp, J. C. Microbiome 5, 9 (2017).

    Article  PubMed  Google Scholar 

  7. Nakatsuji, T. et al. Nature Commun. 4, 1431 (2013).

    Article  PubMed  Google Scholar 

  8. Whittle, E., Leonard, M. O., Harrison, R., Gant, T. W. & Tonge, D. P. Front. Microbiol. 9, 3266 (2018).

    Article  PubMed  Google Scholar 

  9. Poore, G. D. et al. Nature 579, 567–574 (2020).

    Article  Google Scholar 

  10. Geller, L. T. et al. Science 357, 1156–1160 (2017).

    Article  PubMed  Google Scholar 

  11. Riquelme, E. et al. Cell 178, 795–806 (2019).

    Article  PubMed  Google Scholar 

  12. Sethi, V. et al. Gastroenterology 155, 33–37 (2018).

    Article  PubMed  Google Scholar 

  13. Wilson, B. E., Routy, B., Nagrial, A. & Chin, V. T. Cancer Immunol. Immunother. 69, 343–354 (2020).

    Article  PubMed  Google Scholar 

Download references

Competing Interests

J.A.W. is an inventor on a US patent application (PCT/US17/53.717) submitted by the University of Texas MD Anderson Cancer Center that covers methods to enhance immune checkpoint blockade responses by modulating the microbiome. J.A.W. reports compensation for speaker’s bureau and honoraria from Imedex, Dava Oncology, Omniprex, Illumina, Gilead, PeerView, Physician Education Resource, MedImmune, Exelixis, and Bristol-Myers Squibb. J.A.W. serves as a consultant / advisory board member for Roche/Genentech, Novartis, AstraZeneca, GlaxoSmithKline, Bristol-Myers Squibb, Merck, Biothera Pharmaceuticals and Microbiome DX. J.A.W. also receives research support from GlaxoSmithKline, Roche/Genentech, Bristol-Myers Squibb, and Novartis.


Latest on:

Nature Careers


Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing


Quick links